135 related articles for article (PubMed ID: 7713990)
1. Rhythm alteration in patients with metastatic breast cancer and poor prognostic factors.
Touitou Y; Lévi F; Bogdan A; Benavides M; Bailleul F; Misset JL
J Cancer Res Clin Oncol; 1995; 121(3):181-8. PubMed ID: 7713990
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the circadian patterns of serum cortisol in breast and ovarian cancer patients: relationships with tumour marker antigens.
Touitou Y; Bogdan A; Lévi F; Benavides M; Auzéby A
Br J Cancer; 1996 Oct; 74(8):1248-52. PubMed ID: 8883412
[TBL] [Abstract][Full Text] [Related]
3. [Elevation of serum Ca 15-3 antigen: an early indicator of distant metastasis from breast cancer. Retrospective analysis of 733 cases].
Wojtacki J; Kruszewski WJ; Sliwińska M; Kruszewska E; Hajdukiewicz W; Sliwiński W; Rolka-Stempniewicz G; Góralczyk M; Leśniewski-Kmak K
Przegl Lek; 2001; 58(6):498-503. PubMed ID: 11816740
[TBL] [Abstract][Full Text] [Related]
4. The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer.
Wang W; Xu X; Tian B; Wang Y; Du L; Sun T; Shi Y; Zhao X; Jing J
Clin Chim Acta; 2017 Jul; 470():51-55. PubMed ID: 28457854
[TBL] [Abstract][Full Text] [Related]
5. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
Mussi C; Angelini C; Crippa S; Caprotti R; Fumagalli L; Motta V; Uggeri F
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxviii-ccxxxi. PubMed ID: 15244187
[TBL] [Abstract][Full Text] [Related]
6. Cortisol diurnal variation in blood and saliva of patients with metastatic colorectal cancer: relevance for clinical outcome.
Mormon MC; Bogdan A; Cormont S; Touitou Y; Lévi F
Anticancer Res; 2002; 22(2B):1243-9. PubMed ID: 12168933
[TBL] [Abstract][Full Text] [Related]
7. Circadian disruption and biomarkers of tumor progression in breast cancer patients awaiting surgery.
Cash E; Sephton SE; Chagpar AB; Spiegel D; Rebholz WN; Zimmaro LA; Tillie JM; Dhabhar FS
Brain Behav Immun; 2015 Aug; 48():102-14. PubMed ID: 25728235
[TBL] [Abstract][Full Text] [Related]
8. Endocrine and immunological alterations during cancer processes.
Mussi C; Crippa S; Bonardi C; Fontana A; Caprotti R; Uggeri F
Int Surg; 2006; 91(2):68-71. PubMed ID: 16774174
[TBL] [Abstract][Full Text] [Related]
9. HER-2 gene amplification, serum nucleosomes, CEA and CA15.3 tumor markers in breast cancer patients.
Zeiwar MM; Zaki SM; Mohammad LA; Zidan AA; El Nagar MR
Egypt J Immunol; 2007; 14(2):29-41. PubMed ID: 20306655
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of circulating tumor cells (CTCs) with respect to optimal cut-off value and tumor markers in advanced/metastatic breast cancer.
Shiomi-Mouri Y; Kousaka J; Ando T; Tetsuka R; Nakano S; Yoshida M; Fujii K; Akizuki M; Imai T; Fukutomi T; Kobayashi K
Breast Cancer; 2016 Jan; 23(1):120-127. PubMed ID: 24906662
[TBL] [Abstract][Full Text] [Related]
11. Independent prognostic impact of preoperative serum carcinoembryonic antigen and cancer antigen 15-3 levels for early breast cancer subtypes.
Imamura M; Morimoto T; Nomura T; Michishita S; Nishimukai A; Higuchi T; Fujimoto Y; Miyagawa Y; Kira A; Murase K; Araki K; Takatsuka Y; Oh K; Masai Y; Akazawa K; Miyoshi Y
World J Surg Oncol; 2018 Feb; 16(1):26. PubMed ID: 29433529
[TBL] [Abstract][Full Text] [Related]
12. Circadian rhythms of tumor markers in breast cancer patients.
Touitou Y; Bailleul F; Lévi F; Bogdan A; Touitou C; Metzger G; Mechkouri M
Prog Clin Biol Res; 1990; 341A():59-66. PubMed ID: 2217278
[No Abstract] [Full Text] [Related]
13. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer.
Rich T; Innominato PF; Boerner J; Mormont MC; Iacobelli S; Baron B; Jasmin C; Lévi F
Clin Cancer Res; 2005 Mar; 11(5):1757-64. PubMed ID: 15755997
[TBL] [Abstract][Full Text] [Related]
14. Diurnal cortisol rhythm as a predictor of breast cancer survival.
Sephton SE; Sapolsky RM; Kraemer HC; Spiegel D
J Natl Cancer Inst; 2000 Jun; 92(12):994-1000. PubMed ID: 10861311
[TBL] [Abstract][Full Text] [Related]
15. High levels of serum CA15-3 and residual invasive tumor size are associated with poor prognosis for breast cancer patients with non-pathological complete response after neoadjuvant chemotherapy.
Fujimoto Y; Higuchi T; Nishimukai A; Miyagawa Y; Kira A; Ozawa H; Bun A; Imamura M; Miyoshi Y
J Surg Oncol; 2018 Jul; 118(1):228-237. PubMed ID: 29936704
[TBL] [Abstract][Full Text] [Related]
16. [Prevalence of elevated serum CA 15-3 at time of metastatic relapse of breast cancer and correlation with hormone receptor status].
Bensouda Y; André F; Boulet T; Al-Ghuzlan A; Conforti R; Troalen F; Bourgier C; Errihani H; Spielmann M; Delaloge S
Bull Cancer; 2009 Oct; 96(10):923-8. PubMed ID: 19696005
[TBL] [Abstract][Full Text] [Related]
17. Determination of whole body circadian phase in lung cancer patients: melatonin vs. cortisol.
Mazzoccoli G; Giuliani F; Sothern RB
Cancer Epidemiol; 2012 Feb; 36(1):e46-53. PubMed ID: 22000330
[TBL] [Abstract][Full Text] [Related]
18. Interindividual differences in the circadian hematologic time structure of cancer patients.
Bailleul F; Lévi F; Reinberg A; Mathé G
Chronobiol Int; 1986; 3(1):47-54. PubMed ID: 3677193
[TBL] [Abstract][Full Text] [Related]
19. Rhythmic fluctuations of CEA serum levels in breast cancer patients.
Jäger W; Diedrich M; Sauerbrei W; Wildt L
Anticancer Res; 1987; 7(4B):711-5. PubMed ID: 3674759
[TBL] [Abstract][Full Text] [Related]
20. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
